trending Market Intelligence /marketintelligence/en/news-insights/trending/GWt8au9_pBTjAWexJwn4sg2 content esgSubNav
In This List

BioTime plans common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


BioTime plans common stock offering

BioTime Inc. plans to sell common shares in an underwritten public offering.

The company plans to grant the underwriters an overallotment option to buy up to an additional 15% of the shares offered.

BioTime plans to use the net proceeds for general corporate purposes, including, without limitation, to fund clinical trials of products it is developing, to finance its research and development programs, and for working capital.

Raymond James & Associates Inc. will act as the sole book-running manager for the offering.